2021, Vol. 2, Issue 2, Part A

Author(s): Md. Al-Mahdi Talukdar, Ariful Basher Abir and Md. Abdul Mannan

Abstract: Achyranthes aspera Linn. (Amaranthaceae) has been used as a treatment for piles, renal dropsy, kidney stone, snake bite, gonorrhea, and dysentery in Asian people. The recent study was designed to assess the antidepressant effects of the methanolic extract of A. aspera (MEAA) in different behavioral animal models on mice for 14 d treatment. The antidepressant-like activity was evaluated at the doses of 50, 100, and 200 mg/kg in the adult male mice by the forced swimming, tail suspension and open field tests. Deionized water was used as blank for control group. Imipramine hydrochloride (30 mg/kg) was employed as standard drug, respectively. Three test groups were received different doses of the MEAA for 14 d treatment. All substances were administered orally by the use of gavage. The major findings of the methanolic extract of A. aspera significantly reduced immobility times in both mice models for antidepressant-like activity such as FST and TST (*p<0.001). MEAA exhibited dose-dependent antidepressant activity in mice models. On the other hand, to assess the MEAA's motor stimulating activity, we performed an extra OFT. In compared to the control group, the extract also markedly boosted the effects of rearing (*p<0.001), defecation (*p<0.05), and locomotion. The results clearly showed that MEAA exerts an antidepressant-like effects in mice models. Although, need more research on the separation of active ingredients. Before using A. aspera to humans, it is strongly advised to investigate its mechanism of action.

DOI: 10.33545/27072827.2021.v2.i2a.55

Pages: 42-48 | Views: 483 | Downloads: 218

Download Full Article: Click Here